An interview with Dr Javier Labad about family issues and long-acting injectables

An interview with Dr Javier Labad, Sanitaria Parc Tauli Sabadell, Barcelona, Spain about family matters in schizophrenia and long-acting injectable therapies.

When you know that your patient has schizophrenia – is that difficult for you to give them this news? Why is that? Is it the same with their caregiver?

Yes – it is difficult because we often have to deal with several issues at one time. One of these is of course the stigma that is so often attached to a diagnosis of schizophrenia. Another fact is that patients are often very young when they are diagnosed. It can be hard explaining to these young patients how we can overcome this chronic disease, and that regular treatment can allow them to have a good life.

Involving carers is really important – family is a big thing in Spain. At first the family may not quite know what is happening to them and to the patient. If they can contact the psychiatrist and have some of the behaviours explained to them and understand more about schizophrenia, it really helps.

What role do you think long-acting injectable therapies can play?

They can be really important – one of the main problems is that many patients either forget to take tablets, or don’t like to be seen taking their medication – the stigma again. An injectable therapy is so much easier for the patient and compliance. 

The views and opinions expressed on this page do not necessarily reflect those of Otsuka and Lundbeck.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country